Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 35Pancreatic Neoplasms 19Colonic Neoplasms 10Rectal Neoplasms 8Stomach Neoplasms 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Neoplasms 6Neoplasm Metastasis 6Gastrointestinal Neoplasms 6Esophageal Neoplasms 6Carcinoma, Non-Small-Cell Lung 5Biliary Tract Neoplasms 5Advanced Solid Tumors 4Triple Negative Breast Neoplasms 3Melanoma 3Endometrial Neoplasms 3Carcinoma, Squamous Cell 3Adenocarcinoma Of Esophagus 3Squamous Cell Carcinoma of Head and Neck 2Parkinson Disease 4, Autosomal Dominant Lewy Body 2Ovarian Neoplasms 2Liver Neoplasms 2Esophageal Squamous Cell Carcinoma 2Carcinoma, Transitional Cell 2Carcinoma, Hepatocellular 2Carcinoma 2Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC 1Solid Cancer 1Small Cell Lung Carcinoma 1Sarcoma 1

Interventions

tocilizumab 1selicrelumab 1niraparib 1durvalumab 1cobimetinib 1atezolizumab 1Tiragolumab 1Panitumumab 1PEGPH20 1Oxaliplatin 1Optical Imaging 1Nivolumab 1Leucovorin 1Ipilimumab 1Gemcitabine 1Fluorouracil 1Bevacizumab 14-fluorobenzoyl-TN-14003 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Pancreatic Adenocarcinoma × Leucovorin × Clear all
NCT03193190 2025-11-21

A Study of Multiple Immunotherapy-Based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-Pancreatic Cancer)

Hoffmann-La Roche

Phase 1/2 Completed
341 enrolled 28 charts
Gastrointestinal

Pancreatic Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡